Patienterne fortsatte med at få samme dosis venlafaxin depot, som de havde taget ved slutningen af den åbne fase (75, 150 eller 225 mg).
Patients continued to receive the same dose of venlafaxine prolonged-release that they had taken at the end of the open-label phase (75, 150, or 225 mg).